GLP-1 medications work by targeting key processes: Appetite suppression You feel full sooner and stay full longer Slower gastric emptying Food stays in your stomach longer, reducing hunger Blood sugar regulation Helps stabilize glucose levels Reduced cravings Especially for high-calorie foods Tirzepatide adds another layer by also acting on GIP receptors, which may enhance metabolic effects
These medications are administered via subcutaneous injection, usually weekly, and require dose titration to minimize gastrointestinal adverse effects
Miracles up to a point
There have already been reports of organizations reversing previous coverage of GLP-1 for obesity due to high utilization and extremely high costs to the plan
Scirica BM, Bhatt DL, Braunwald E, et al
Despite limited big pharma involvement, venture funding is propelling new companies, potentially reshaping the industry landscape